OTC · Biotechnology

OncoVista Innovative Therapies, Inc. (OVIT) Stock

$0.00 OTC: OVIT Healthcare

OncoVista Innovative Therapies, Inc. does not have significant business.

Valuation

MetricValue
Price$0.00
Market Cap$2356
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.12
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE50.00%
ROA—
ROCE51.29%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric20102011201220132014
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-2.0M$-2.0M$-2.0M$-3.0M
Net Profit$10.0M$-2.0M$-2.0M$-1.0M$-3.0M
EPS$-0.11$-0.10$-0.08$-0.07$-0.12
Op Margin—————

Balance Sheet (USD)

Metric20102011201220132014
Total Assets$4.0M$2.0M$1.0M$0$0
Total Liabilities$2.0M$2.0M$2.0M$3.0M$6.0M
Cash$4.0M$2.0M$1.0M$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20102011201220132014
Operating Cash Flow$-1.0M$-2.0M$-2.0M$0$0
Investing Cash Flow$6.0M$0$0$0$0
Financing Cash Flow$-1.0M$0$0$0$0
Net Cash Flow$3.0M$-1.0M$-2.0M$0$0
Free Cash Flow$-1.0M$-2.0M$-2.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.08
FCF Yield-9863.50%
Quick Ratio0.00
Interest Coverage-305.91
Return 1Y0.00%
Return 3Y-50.00%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Safeguard Financial, LLC 1,3002023-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTHAnthera Pharmaceuticals, Inc. $0.00 — 0.00 $2618 0.00%
COTQFCotinga Pharmaceuticals Inc. $0.00 — 0.00 $2199 0.00%
FORUForU Holdings, Inc. $0.00 — 0.00 $2171 0.00%
LPTILongport, Inc. $0.00 — — $2308 0.00%
NEWGGreenwind Holdings Inc. $0.00 — -0.11 $2260 0.00%

About OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc. does not have significant business. Previously, it engaged in development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas.

OncoVista Innovative Therapies, Inc. (OVIT) stock trades at $0.00 with a market capitalization of $2356. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, OncoVista Innovative Therapies, Inc. generates a return on equity (ROE) of 50.00% — well above the market average, a sign of a high-quality business, return on capital employed of 51.29%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.oncovista.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides